
For research use only. We do not supply to patients.
For pharmaceutical-grade products or other inquiries, please contact our experts.
Due to loratadine’s (LOR) low aqueous solubility, which requires high-dose formulations for adequate bioavailability, researchers developed novel LOR-glycerin nanoparticles (LOR-GNPs) via precipitation. Characterization showed uniform particles (334±30 nm by DLS) with varied morphologies (SEM) and high entrapment efficiency (98.1±0.3% by titration). Formulated into a hydrogel, the system demonstrated suitable viscosity, spreadability, and homogeneity. Permeation studies confirmed nanoparticle penetration through rat abdominal skin. The LOR-GNP hydrogel significantly improved LOR solubility and bioavailability, presenting a promising delivery strategy.
Fig. 2 Scanning electron microscope images of blank GNPs and LORGNPs. (Abou-Taleb H A, et al. 2017)
References
Cat NO.: CHE100165911
CAS NO.: 100165-91-1
Cat NO.: CHE82372358
CAS NO.: 82372-35-8
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed
All our products are chemicals for research purposes only. We do not supply for human or veterinary applications.
Privacy Policy | Cookie Policy Copyright © Protheragen. All Rights Reserved.
